Impact of First-Line Antifungal Agents on the Outcomes and Costs of Candidemia

Candida species are the leading causes of invasive fungal infection among hospitalized patients and are responsible for major economic burdens. The goals of this study were to estimate the costs directly associated with the treatment of candidemia and factors associated with increased costs, as well...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ha, Young Eun, Peck, Kyong Ran, Joo, Eun-Jeong, Kim, Shin Woo, Jung, Sook-In, Chang, Hyun Ha, Park, Kyong Hwa, Han, Sang Hoon
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2012
Assuntos:
Clinical Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3393400/
https://ncbi.nlm.nih.gov/pubmed/22526315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.06258-11
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares